← Open Payments lookup

SHAHRZAD ARJOMANDI: Open Payments

NPI 1124746318 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$664 in 31 payments from 12 companies in 2025. Trend: 2023 $790 · 2024 $3,078 · 2025 $664

Food & beverage: $664
CompanyPaymentsAmount
ABBVIE INC.11$163
Vanda Pharmaceuticals Inc.4$133
Alkermes, Inc.3$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Otsuka America Pharmaceutical, Inc.2$44
Teva Pharmaceuticals USA, Inc.2$42
Neurocrine BioSciences, Inc.1$37
Biogen, Inc.1$30
Indivior Inc.1$24
Axsome Therapeutics, Inc.1$22

Products named: VRAYLAR, HETLIOZ, ARISTADA, CAPLYTA, INGREZZA, ZURZUVAE, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.